The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related Practice

January 11, 2026 updated by: Nuzul Sri Hertanti, Taipei Medical University

The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related Practice: a Cluster Randomized Controlled Trial

This cluster randomized controlled trial aims to evaluate the effectiveness of an educational board game compared to a lecture-based intervention on improving knowledge, attitudes, and confidence in dengue-related practice among nurses working in primary healthcare (PHC) units. Additionally, the study will assess PHC nurses' satisfaction with the learning experience. A total of 82 participants from 14 PHC unit clusters in Yogyakarta, Indonesia will be randomly assigned to either the intervention group (educational board game) or the control group (lecture-based intervention). Each group will receive a one-time 90-minute session of assigned intervention. Outcomes related to knowledge, attitudes, and confidence will be measured at multiple time points.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Considering the multiple roles of PHC nurses in dengue prevention and management, there is a need for training methods that are not only informative but also actively engaging and time-efficient. Educational board games offer a promising interactive learning strategy. However, their application among healthcare professionals, particularly nurses, remains underexplored.

The main purpose of this study is to examine whether an educational board game can improve PHC nurses' knowledge, attitudes, and confidence in dengue-related practice compared to a lecture-based intervention. In addition, the study will evaluate participants' satisfaction with the learning experience.

This two-arm parallel cluster randomized controlled trial will be conducted in Yogyakarta, Indonesia, involving 82 participants from 14 PHC unit clusters. These clusters will be randomly allocated into two groups: the intervention group (educational board game) and the control group (lecture-based intervention). Each group will receive a single 90-minute educational session.

Outcomes on knowledge, attitudes, and confidence will be assessed at multiple time points. Data will be analyzed using a linear mixed-effects model (LMM) to evaluate the interaction effects between group and time. Findings from this study may offer valuable insights for healthcare institutions and policymakers to consider integrating board games into professional training and continuing professional development (CPD) programs.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
106

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Indonesia
    • Special Region of Yogyakarta
      • Yogyakarta, Special Region of Yogyakarta, Indonesia, 55111
        • Primary Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Full-time employed nurses in the PHC unit
  • Nurses who have experience in assessing dengue-suspected patients
  • Nurses who have at least three months of work experience in the current PHC unit
  • Nurses who have a smartphone for online communication
  • Nurses who are familiar with WhatsApp applications

Exclusion Criteria:

  • Nurses on maternity or annual leave during the data collection period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Educational board game
Participants will receive an educational board game one time for 90 minutes.
Behavioral: Educational board game
The educational board game will be administered once for a duration of 90 minutes, consisting of a gameplay session followed by a debriefing.
Active Comparator: Lecture group
Participants will receive a lecture-based intervention one time for 90 minutes.
Behavioral: Lecture
The lecture will be administered once for a duration of 90 minutes, consisting of video lecture followed by question and answer (QnA) session.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knowledge
Time Frame: Baseline, immediately after intervention, and follow up at one-month post intervention.
This study will use the Indonesian version of Dengue Knowledge Questionnaire to measure PHC nurses' knowledge of dengue. The questionnaire consists of seven items, with response options of "true," "false," or "unknown." Each correct answer will receive 1 point, while incorrect or unknown responses receive 0 points. Total scores range from 0 to 7, with higher scores reflecting a better knowledge of dengue.
Baseline, immediately after intervention, and follow up at one-month post intervention.
Attitude
Time Frame: Baseline, immediately after intervention, and follow up at one-month post intervention.
The study will use the Indonesian version of Dengue Preventive Attitudes Questionnaire to measure nurses' attitudes toward dengue prevention. It consists of seven items, each rated on a five-point Likert scale, with 1 indicating "strongly disagree" and 5 indicating "strongly agree." Total scores range from 7 to 35, with higher scores representing more favorable attitudes toward dengue prevention.
Baseline, immediately after intervention, and follow up at one-month post intervention.
Confidence
Time Frame: Baseline, immediately after intervention, and follow up at one-month post intervention.
The study will use the Indonesian version of the five-item Confidence-Scale (C-Scale) to measure nurses' confidence in their practice. Responses will be recorded on a five-point Likert scale, ranging from 1 to 5, with 5 indicating "higher confidence." Total scores ranged from 5 to 25, with higher scores indicating greater confidence.
Baseline, immediately after intervention, and follow up at one-month post intervention.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Learning satisfaction
Time Frame: Immediately after intervention.
This study will use the Indonesian version of the five-item Satisfaction in Learning questionnaire to assess nurses' satisfaction with the assigned learning methods. Responses will be recorded on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Higher score indicated more satisfied with learning methods.
Immediately after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Taipei Medical University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nuzul S Hertanti, RN, MS, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 8, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 21, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 21, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 11, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 11, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 19, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 11, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KE/FK/0902/EC/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings